Delivery Order SPE2DR25D2006-SPE2DR26F56WF
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,934.70 to AmerisourceBergen Drug Corp for the supply of Leucovorin Calcium 500 mg vials. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of November 10, 2025, and represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery order carries no set-aside designation and will be performed at...
- The Defense Logistics Agency Troop Support Medical awarded a $1,859 firm fixed price delivery order to Amerisourcebergen Drug Corp for 25mg tablets of Leucovorin Calcium. The delivery order is for 25 tablets to be shipped to Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period beginning and ending on August 10-11, 2023. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, which will perform as the prime contractor without the use of major...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,169.85 contract is for the supply of 500 mg vials of the drug leucovorin calcium. The delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through...
- The Defense Logistics Agency awarded a delivery order valued at $1,532.42 to AmerisourceBergen Drug Corp on December 17, 2025, under the Pharmaceutical Pharmacovigilance Division contract. This firm fixed price delivery order, which has no set-aside designation, is scheduled for completion by December 18, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on July 14, 2025, for the supply of Lazcluze 240 mg tablets in quantities of 30 units. This firm fixed price delivery order carries a ceiling value of $12,446.16 and is scheduled for completion by August 4, 2025. The award was made through open competition with no set-aside designation, and the pharmaceutical products will be delivered to the contractor's location in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Lazicluze 240 mg tablets (30-count units) with a ceiling value of $12,446.16. This firm fixed-price delivery order, with an ultimate completion date of July 9, 2025, represents a non-competitive set-aside transaction executed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, a major...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $578,935.47 to AmerisourceBergen Drug Corp on December 12, 2025, with an ultimate completion date of December 15, 2025. This firm fixed price delivery order, issued without a set-aside designation, represents a competitively awarded procurement that leverages AmerisourceBergen's established relationship with the federal government as a critical pharmaceutical distributor. The contract is performed at the...
- The Defense Logistics Agency awarded a $4,782.46 delivery order to AmerisourceBergen Drug Corp for the supply of Levorphanol 2 mg tablets (100-count units) on September 3, 2025, with an ultimate completion date of September 4, 2025. This non-set-aside contract employs firm fixed-price pricing and represents a competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The performance location for this pharmaceutical...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,270.19 firm fixed-price delivery order is for LEVORPHANOL TABS 2MG, with a period of performance through March 25, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, with a ceiling value of $551,900.70 under a firm fixed price contract. This non-set-aside delivery order is expected to be completed by December 9, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under a larger indefinite delivery vehicle, leveraging AmerisourceBergen's...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F56WFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Leucovorin Calcium 25 mg tablets in unit dose packaging (20 count), with a contract ceiling value of $1,157.22. This firm fixed-price delivery order is not set-aside and will be completed by December 18, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a continuation of the company's role as a critical pharmaceutical supplier to federal medical procurement needs. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's substantial federal contract portfolio demonstrates its capacity to fulfill competitive procurement requirements across multiple therapeutic domains in support of Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/16/25 |